207 related articles for article (PubMed ID: 27651313)
1. In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging.
Longo DL; Bartoli A; Consolino L; Bardini P; Arena F; Schwaiger M; Aime S
Cancer Res; 2016 Nov; 76(22):6463-6470. PubMed ID: 27651313
[TBL] [Abstract][Full Text] [Related]
2. Tumor pH Imaging Using Chemical Exchange Saturation Transfer (CEST)-MRI.
Longo DL; Pirotta E; Gambino R; Romdhane F; Carella A; Corrado A
Methods Mol Biol; 2023; 2614():287-311. PubMed ID: 36587132
[TBL] [Abstract][Full Text] [Related]
3. A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH.
Lindeman LR; Randtke EA; High RA; Jones KM; Howison CM; Pagel MD
Magn Reson Med; 2018 May; 79(5):2766-2772. PubMed ID: 29024066
[TBL] [Abstract][Full Text] [Related]
4. Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH.
Anemone A; Consolino L; Arena F; Capozza M; Longo DL
Cancer Metastasis Rev; 2019 Jun; 38(1-2):25-49. PubMed ID: 30762162
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI.
Jardim-Perassi BV; Irrera P; Lau JYC; Budzevich M; Whelan CJ; Abrahams D; Ruiz E; Ibrahim-Hashim A; Damgaci Erturk S; Longo DL; Pilon-Thomas SA; Gillies RJ
Contrast Media Mol Imaging; 2023; 2023():1944970. PubMed ID: 36704211
[TBL] [Abstract][Full Text] [Related]
6. pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI.
Harris RJ; Cloughesy TF; Liau LM; Prins RM; Antonios JP; Li D; Yong WH; Pope WB; Lai A; Nghiemphu PL; Ellingson BM
Neuro Oncol; 2015 Nov; 17(11):1514-24. PubMed ID: 26113557
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging.
Anemone A; Consolino L; Conti L; Reineri F; Cavallo F; Aime S; Longo DL
Int J Oncol; 2017 Aug; 51(2):498-506. PubMed ID: 28714513
[TBL] [Abstract][Full Text] [Related]
8. CEST-MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry.
Ferrauto G; Di Gregorio E; Auboiroux V; Petit M; Berger F; Aime S; Lahrech H
NMR Biomed; 2018 Nov; 31(11):e4005. PubMed ID: 30256478
[TBL] [Abstract][Full Text] [Related]
9. Multislice CEST MRI improves the spatial assessment of tumor pH.
Randtke EA; Granados JC; Howison CM; Pagel MD; Cárdenas-Rodríguez J
Magn Reson Med; 2017 Jul; 78(1):97-106. PubMed ID: 27465207
[TBL] [Abstract][Full Text] [Related]
10. A machine learning approach that measures pH using acidoCEST MRI of iopamidol.
Li T; Cárdenas-Rodríguez J; Trakru PN; Pagel MD
NMR Biomed; 2023 Oct; 36(10):e4986. PubMed ID: 37280721
[TBL] [Abstract][Full Text] [Related]
11. Development of a Nanoscale Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agent That Measures pH.
Kombala CJ; Kotrotsou A; Schuler FW; de la Cerda J; Ma JC; Zhang S; Pagel MD
ACS Nano; 2021 Dec; 15(12):20678-20688. PubMed ID: 34870957
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a similarity anisotropic diffusion denoising approach for improving in vivo CEST-MRI tumor pH imaging.
Romdhane F; Villano D; Irrera P; Consolino L; Longo DL
Magn Reson Med; 2021 Jun; 85(6):3479-3496. PubMed ID: 33496986
[TBL] [Abstract][Full Text] [Related]
13. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
McVicar N; Li AX; Meakin SO; Bartha R
NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190
[TBL] [Abstract][Full Text] [Related]
14. Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI.
Chen M; Chen C; Shen Z; Zhang X; Chen Y; Lin F; Ma X; Zhuang C; Mao Y; Gan H; Chen P; Zong X; Wu R
Oncotarget; 2017 Jul; 8(28):45759-45767. PubMed ID: 28501855
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
[TBL] [Abstract][Full Text] [Related]
16. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
Apostolova I; Wedel F; Brenner W
Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
19. Glucose Infusion Induced Change in Intracellular pH and Its Relationship with Tumor Glycolysis in a C6 Rat Model of Glioblastoma.
Qi Q; Fox MS; Lim H; Sullivan R; Li A; Bellyou M; Desjardins L; McClennan A; Bartha R; Hoffman L; Scholl TJ; Lee TY; Thiessen JD
Mol Imaging Biol; 2023 Apr; 25(2):271-282. PubMed ID: 36418769
[TBL] [Abstract][Full Text] [Related]
20. A comparison of iopromide and iopamidol, two acidoCEST MRI contrast media that measure tumor extracellular pH.
Moon BF; Jones KM; Chen LQ; Liu P; Randtke EA; Howison CM; Pagel MD
Contrast Media Mol Imaging; 2015; 10(6):446-55. PubMed ID: 26108564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]